The aim of the Master's Degree in Preclinical and Clinical Drug Research and Development is to provide comprehensive interdisciplinary training in all the scientific, regulatory, ethical, organizational, and promotional aspects of new drug development. This program brings together topics that are rarely covered or entirely absent from other degree programs in Medicine, Pharmacy, Biology, and CTF.
Consequently, those who complete the master's program have comprehensive training in the research and development of new drugs, not only theoretically but also practically, as participants are generally already working in this field or complement their theoretical training with an internship at a pharmaceutical company or a CRO, a hospital clinical research center, or the Scientific Secretariat of a hospital ethics committee.
Activation of the master's program is subject to approval by the university bodies.
The course is held in Italian and/or English.
The ongoing exams will be held in person (the hours required for the three tests are not counted towards the total number of hours). On the day of the exam, lessons will be held in person.
The final exam consists of the discussion of a paper on topics related to the internship or project work experience.
Dipartimento di Medicina e Chirurgia
Manager of clinical study organization and management
Quality verification and compliance manager for studies
In pharmaceutical companies, CROs, and large research institutes.
At research hospitals and IRCCSs, in public institutions such as ASLs or AIFA.
Coordination and secretarial activities of the ASL Ethics Committee